| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/24/2003 | DE20220609U1 Cosmetic for reinforcing skin regeneration and treating skin irritations such as acne contains the cyclic form of D-ribose in an aqueous solution |
| 12/24/2003 | DE10225635C1 N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung N-Benzoylureido-cinnamic acid derivatives, processes for their preparation and their use |
| 12/24/2003 | CN2593786Y Nano medicines against AIDS and hepatitis B |
| 12/24/2003 | CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore |
| 12/24/2003 | CN1463269A Phenylpiperazine |
| 12/24/2003 | CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof |
| 12/24/2003 | CN1463177A Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds |
| 12/24/2003 | CN1462754A Medicinal complex dibaicalin zinc and its preparation method |
| 12/24/2003 | CN1462752A Chemotherapy medication-coupler of gem-bis phosphoric acid and synthetic method as well as usage |
| 12/24/2003 | CN1462751A Method for preparing crystalline cefathiamidine and its usage |
| 12/24/2003 | CN1462750A Erigeron ester B and its preparation method as well as application in pharmacy |
| 12/24/2003 | CN1462620A Powder of flenabane and its preparation method as well as application in making drugs |
| 12/24/2003 | CN1462619A Medicine use of cooperation substance of zinc glycoside of baikal skullcap root |
| 12/24/2003 | CN1462618A Fibrauretine in dosage form of decentralization tablet |
| 12/24/2003 | CN1462617A Alkaloid oral applied drop pills possessing anticarcinogenesis and its preparation method |
| 12/24/2003 | CN1462584A Externally-used disinfector |
| 12/24/2003 | CN1131871C Prepn. of sterol ester and steriod esters |
| 12/24/2003 | CN1131870C 新的吡咯磺酰胺化合物 The new pyrrole sulfonamide compound |
| 12/24/2003 | CN1131869C 新的含三(噁唑)的细胞毒性大环内酯化合物 New cytotoxic macrolide compounds containing tris (oxazole) of |
| 12/24/2003 | CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine |
| 12/24/2003 | CN1131867C 一种诱导编程性细胞死亡的化合物、其制备方法及其组合物 A compound of apoptosis induction, their preparation and their compositions |
| 12/24/2003 | CN1131865C 作为选择性COX－2抑制剂的取代的咪唑并[1,2a]吖嗪 Substituted imidazole as selective COX-2 inhibitors and [1,2a] azines |
| 12/24/2003 | CN1131864C 吗啉衍生物的化学合成方法 Morpholine derivatives chemical synthesis |
| 12/24/2003 | CN1131862C 经吡咯烷基、哌啶基或高哌啶基取代的(苯并二噁烷,苯并呋喃或苯并吡喃)衍生物 After pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 12/24/2003 | CN1131861C Piperazidine deriv. and preparing method thereof |
| 12/24/2003 | CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate |
| 12/24/2003 | CN1131858C 旋光的氨基戊烷衍生物 Aminopentane optically active derivatives |
| 12/24/2003 | CN1131856C 作为黄体酮受体调节剂的环硫代氨基甲酸酯衍生物 As cyclic thiocarbamate derivative of progesterone receptor modulators |
| 12/24/2003 | CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy |
| 12/24/2003 | CN1131854C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists |
| 12/24/2003 | CA2779633A1 Combination of azelastine and steroids |
| 12/24/2003 | CA2779630A1 Combination of azelastine and steroids |
| 12/24/2003 | CA2491846A1 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof |
| 12/24/2003 | CA2489870A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | CA2489854A1 Antifungal medicinal compositions |
| 12/24/2003 | CA2489791A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of anxiety or depression |
| 12/24/2003 | CA2489708A1 A process for the preparation of piroxicam: .beta.-cyclodextrin inclusion compounds |
| 12/24/2003 | CA2489648A1 Chemical process |
| 12/24/2003 | CA2489605A1 Oxaliplatin anti-resistance agent |
| 12/24/2003 | CA2489594A1 Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 12/24/2003 | CA2489592A1 Inhibitor of anticancer drug side effect |
| 12/24/2003 | CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | CA2489459A1 Condensed palatinose and method for producing the same |
| 12/24/2003 | CA2489458A1 Substituted diaminopyrimidines |
| 12/24/2003 | CA2489450A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 12/24/2003 | CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | CA2489377A1 Novel crystalline forms of gatifloxacin |
| 12/24/2003 | CA2489367A1 Compounds, compositions, and methods |
| 12/24/2003 | CA2489357A1 Aryl phosphate derivatives with selective activity against adenovirus and hiv |
| 12/24/2003 | CA2489355A1 Methods of using isothiazole derivatives to treat cancer or inflammation |
| 12/24/2003 | CA2489315A1 Formulation of nefopam and its use in the treatment of pain |
| 12/24/2003 | CA2489312A1 Modulation of activation of glucocorticoid receptors .beta.-breakdown products of glucocorticoids |
| 12/24/2003 | CA2489306A1 Use of nefopam for the treatment of nausea or emesis |
| 12/24/2003 | CA2489293A1 O-sulphated bacterial polysaccharides and their use |
| 12/24/2003 | CA2489292A1 Vectors for expression of hml-2 polypeptides |
| 12/24/2003 | CA2489286A1 2-naphtamide derivatives |
| 12/24/2003 | CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | CA2489250A1 Composition comprising viscous fibers and viscosity-lowering proteins |
| 12/24/2003 | CA2489249A1 Carboxamides derivatives |
| 12/24/2003 | CA2489247A1 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 12/24/2003 | CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament |
| 12/24/2003 | CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | CA2489179A1 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/24/2003 | CA2489130A1 Preparations containing conjugated linoleic alcohol |
| 12/24/2003 | CA2489106A1 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | CA2489098A1 Bazedoxifene treatment regimens |
| 12/24/2003 | CA2489095A1 Aspartyl protease inhibitors |
| 12/24/2003 | CA2489004A1 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | CA2488891A1 Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
| 12/24/2003 | CA2488884A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | CA2488880A1 Quinone-based therapeutic agent for hepatopathy |
| 12/24/2003 | CA2488879A1 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 12/24/2003 | CA2488858A1 Immunotoxin as a therapeutic agent and uses thereof |
| 12/24/2003 | CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension |
| 12/24/2003 | CA2488842A1 Carbocyclic nucleoside analogs as rna-antivirals |
| 12/24/2003 | CA2488802A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | CA2488752A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | CA2488643A1 Coated particles, methods of making and using |
| 12/24/2003 | CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid |
| 12/24/2003 | CA2488407A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 12/24/2003 | CA2488138A1 Treatment for depression and anxiety by the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent |
| 12/24/2003 | CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | CA2488111A1 Beverages containing plant sterols |
| 12/24/2003 | CA2488026A1 Powdery respiratory tonic composition |
| 12/24/2003 | CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 12/24/2003 | CA2487122A1 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 12/24/2003 | CA2486557A1 Calcium salts of indole derived statins |
| 12/24/2003 | CA2486215A1 Mitotic kinesin inhibitors |
| 12/24/2003 | CA2485751A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions |
| 12/24/2003 | CA2485346A1 Human adam-10 inhibitors |
| 12/24/2003 | CA2485090A1 Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (no-bisphosphonate) |
| 12/24/2003 | CA2464109A1 Process for the preparation of oxazolidinones and method of use thereof |
| 12/23/2003 | US6667404 Retroviral protease inhibiting compounds |
| 12/23/2003 | US6667393 Azalide antibiotic compositions |
| 12/23/2003 | US6667346 Method for protecting cells and tissues from ionizing radiation toxicity with α, β unsaturated aryl sulfones |
| 12/23/2003 | US6667345 Derivatives of C2-substituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 12/23/2003 | US6667344 Formoterol, or a derivative; long term storage stability |
| 12/23/2003 | US6667343 For dyeing human keratin fibers, especially hair, or for make-up; may also be used in foods and pharmaceuticals |